Moreover, the annotation analysis of the targets of PAH, CD, and UC TFs, according to the GRN, shows that they are involved in multiple cellular processes, signaling pathways, and epigenetic reprogramming, suggesting that they could potentially become gut–lung inflammatory and cancer early detection biomarkers and therapeutic targets (Table 2). This evidence concerns the gene GRN and cancer.